148 related articles for article (PubMed ID: 37850770)
1. Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): a cross-sectional study.
Alshurafa A; Soliman AT; De Sanctis V; Ismail O; Abu-Tineh M; Hemadneh MKE; Rashid FR; Yassin K; Qasim H; Nashwan AJ; Yassin MA
Acta Biomed; 2023 Oct; 94(5):e2023198. PubMed ID: 37850770
[TBL] [Abstract][Full Text] [Related]
2. Core decompression in avascular necrosis of the hip in sickle-cell disease.
Styles LA; Vichinsky EP
Am J Hematol; 1996 Jun; 52(2):103-7. PubMed ID: 8638629
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.
Yu T; Campbell T; Ciuffetelli I; Haywood C; Carroll CP; Resar L; Strouse JJ; Lanzkron S
South Med J; 2016 Sep; 109(9):519-24. PubMed ID: 27598353
[TBL] [Abstract][Full Text] [Related]
4. Core decompression and arthroplasty outcomes for atraumatic osteonecrosis of the humeral head.
Kennon JC; Smith JP; Crosby LA
J Shoulder Elbow Surg; 2016 Sep; 25(9):1442-8. PubMed ID: 27085764
[TBL] [Abstract][Full Text] [Related]
5. Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study.
Akinyoola AL; Adediran IA; Asaleye CM
Niger Postgrad Med J; 2007 Sep; 14(3):217-20. PubMed ID: 17767206
[TBL] [Abstract][Full Text] [Related]
6. Complete resolution of stage II avascular necrosis affecting three joints by hyperbaric oxygen in a patient with sickle cell disease: A case report.
Alshurafa A; Elhissi M; Yassin MA
Front Med (Lausanne); 2022; 9():1063255. PubMed ID: 36530906
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and impact of orthopaedic monitoring on the outcome of avascular necrosis of the femoral head in adults with sickle cell disease: 215 patients case study with control group.
Mukisi-Mukaza M; Saint Martin C; Etienne-Julan M; Donkerwolcke M; Burny ME; Burny F
Orthop Traumatol Surg Res; 2011 Dec; 97(8):814-20. PubMed ID: 22079613
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of avascular necrosis in patients with sickle cell disease: Children's Hospital Oakland Hip Evaluation Scale--a modification of the Harris Hip Score.
Aguilar CM; Neumayr LD; Eggleston BE; Earles AN; Robertson SM; Jergesen HE; Stulberg BN; Vichinsky EP
Arch Phys Med Rehabil; 2005 Jul; 86(7):1369-75. PubMed ID: 16003666
[TBL] [Abstract][Full Text] [Related]
9. Vaso-occlusive crisis as a predictor of symptomatic avascular necrosis in children with sickle cell disease.
Mesleh Shayeb A; Smeltzer MP; Kaste SC; Brown A; Estepp JH; Nottage KA
Pediatr Blood Cancer; 2018 Dec; 65(12):e27435. PubMed ID: 30183122
[TBL] [Abstract][Full Text] [Related]
10. Core Decompression and Bone Marrow Aspirate Concentrate in the Treatment of Femoral Head Avascular Necrosis in Pediatric Sickle Cell Disease: Can We Improve Natural History?
Griffith MS; Shaw KA; Hattaway JK; Schrader T
J Pediatr Orthop; 2021 Nov-Dec 01; 41(10):604-609. PubMed ID: 34419981
[TBL] [Abstract][Full Text] [Related]
11. Radiological manifestation of avascular necrosis (AVN) in sickle cell disease (SCD): a review of diagnostic imaging.
Bedair E; Almaslamani N; Yassin M
Acta Biomed; 2023 Jun; 94(3):e2023177. PubMed ID: 37326259
[TBL] [Abstract][Full Text] [Related]
12. Impact of sickle cell disease in shoulder arthroplasty: a matched cohort analysis.
Marigi EM; Triplet JJ; Alder KD; Cheema A; Sperling JW; Sanchez-Sotelo J
J Shoulder Elbow Surg; 2023 Feb; 32(2):247-252. PubMed ID: 36115611
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging in children with sickle cell disease--detecting alterations in the apparent diffusion coefficient in hips with avascular necrosis.
Mackenzie JD; Hernandez A; Pena A; Ruppert K; Khrichenko D; Gonzalez L; Jawad AF; Wells L; Smith-Whitley K; Jaramillo D
Pediatr Radiol; 2012 Jun; 42(6):706-13. PubMed ID: 22200862
[TBL] [Abstract][Full Text] [Related]
14. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
[TBL] [Abstract][Full Text] [Related]
15. Avascular necrosis in sickle cell (homozygous S) patients: predictive clinical and laboratory indices.
Madu AJ; Madu AK; Umar GK; Ibekwe K; Duru A; Ugwu AO
Niger J Clin Pract; 2014; 17(1):86-9. PubMed ID: 24326814
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid injections for treatment of pediatric sickle cell avascular necrosis of the humeral head.
Wong JY; Le S; Lo C; Costandi A; Chernishof V; Kim E
Reg Anesth Pain Med; 2022 Feb; 47(2):136-138. PubMed ID: 34642239
[TBL] [Abstract][Full Text] [Related]
17. The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease.
Kutlar A; Kutlar F; Turker I; Tural C
Hemoglobin; 2001 May; 25(2):213-7. PubMed ID: 11480782
[TBL] [Abstract][Full Text] [Related]
18. Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease.
Zimmerman SA; Ware RE
Am J Hematol; 1998 Dec; 59(4):267-72. PubMed ID: 9840906
[TBL] [Abstract][Full Text] [Related]
19. Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients.
Al Omran A
Arch Orthop Trauma Surg; 2013 May; 133(5):609-13. PubMed ID: 23494112
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Periprosthetic Fractures in Total Hip Arthroplasty in Patients With Sickle Cell Disease at King Fahad Hospital Hofuf: A Cross-Sectional Study.
Alsaleem MK; Alalwan HA; Alkhars AM; Al Huwaiyshil AH; Alamri WM
Cureus; 2020 Nov; 12(11):e11390. PubMed ID: 33312790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
